Association of Age at First Severe Respiratory Syncytial Virus Disease With Subsequent Risk of Severe Asthma: A Population-Based Cohort Study.
Age Factors
Age of Onset
Asthma
/ epidemiology
Child, Preschool
Cohort Studies
Female
Hospitalization
Humans
Incidence
Infant
Infant, Newborn
Male
New South Wales
/ epidemiology
Respiratory Syncytial Virus Infections
/ complications
Respiratory Syncytial Virus Vaccines
/ administration & dosage
Respiratory Syncytial Viruses
/ immunology
Retrospective Studies
Risk
Age at first RSV
RSV vaccine
asthma
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
19 07 2019
19 07 2019
Historique:
received:
05
09
2018
accepted:
19
11
2018
pubmed:
6
12
2018
medline:
9
6
2020
entrez:
6
12
2018
Statut:
ppublish
Résumé
In a population-based cohort study, we determined the association between the age at first severe respiratory syncytial virus (RSV) disease and subsequent asthma. Incidence rates and rate ratios of the first asthma-associated hospitalization after 2 years of age in children hospitalized for RSV disease at <3 months, 3 to <6 months, 6 to <12 months, and 12-24 months of age were calculated. The incidence of asthma-associated hospitalization per 1000 child-years among children hospitalized for RSV disease at <3 months of age was 0.5 (95% confidence interval [CI], .2-.7); at 3 to <6 months of age, 0.9 (95% CI,.5-1.3); at 6 to <12 months of age, 2.0 (95% CI, 1.4-2.7); and at 12-24 months of age, 1.7 (95% CI, 1.0-2.5). The rate ratio of hospitalization for asthma was 2-7-fold greater among children hospitalized for RSV disease at ages ≥6 months than that among those hospitalized for RSV disease at ages 0 to <6 months. Although the burden of RSV disease is highest in children aged <6 months, the burden of subsequent asthma is higher in children who develop RSV disease at ages ≥6 months.
Identifiants
pubmed: 30517699
pii: 5210935
doi: 10.1093/infdis/jiy671
doi:
Substances chimiques
Respiratory Syncytial Virus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
550-556Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.